clinical trial · NCT06804811
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
NonSegmental VitiligoRuxolitinib CreamVehicle Cream
brief summary
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in children (6 to \< 12 years old) with nonsegmental vitiligo.
started
Nov 13, 2025
primary completion
Apr 30, 2027
completion
Dec 1, 2027
last updated
Jul 14, 2026
official title
A Phase 3, Randomized, Double-Blind, Efficacy, and Safety Study of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol